Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-044061

Options or other derivatives

  • Chief Patient Supply Officer acquired 1,027,068 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lunger John Chief Patient Supply Officer 2019-08-01 Grant or award · Option to purchase Ordinary Shares +839,568 839,568 D
Lunger John Chief Patient Supply Officer 2019-08-01 Grant or award · Option to purchase Ordinary Shares +187,500 187,500 D
Loading xslF345X03/a4.xml…